Uptrend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up since Oct 7 · above the Ichimoku cloud · RSI 70 (overbought) · MACD above its signal
None of the 29 investors followed here reported a position in RMD.AX in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a RMD.AX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for RMD.AX.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.5 | -3.9 | -10.8 | -7.4 | -3.5 | 0.5 | 3.2 | 10.9 | -3.2 | 5.0 | −6.6% | ||
| 2025 | 9.3 | -7.6 | -5.8 | 4.9 | 3.4 | 3.8 | 7.9 | -0.9 | -2.5 | -3.7 | -0.6 | -8.6 | −2.3% |
| 2024 | 14.8 | -8.7 | 13.1 | 9.0 | -4.4 | -7.3 | 11.6 | 9.9 | -2.1 | 5.6 | 4.0 | -4.2 | +44.5% |
| 2023 | 3.7 | -2.1 | 3.1 | 4.1 | -3.7 | 1.1 | 2.5 | -24.2 | -7.4 | -7.7 | 11.7 | 4.5 | −17.8% |
| 2022 | -10.8 | 4.7 | -2.9 | -10.1 | 0.1 | 5.2 | 11.5 | -6.1 | 5.3 | 0.7 | -1.8 | -7.4 | −13.5% |
| 2021 | -0.0 | -9.8 | 2.9 | 3.6 | 3.6 | 20.8 | 10.3 | 11.3 | -7.3 | -0.2 | -2.4 | -1.4 | +31.4% |
| 2020 | 14.4 | -2.4 | 1.0 | -5.2 | 1.4 | 16.1 | 2.7 | -13.9 | -1.9 | 16.9 | 1.2 | -3.6 | +24.3% |
| 2019 | -17.9 | 11.0 | -0.4 | 1.5 | 11.2 | 5.2 | 10.7 | 8.4 | -3.7 | 7.2 | 4.3 | -1.3 | +37.6% |
| 2018 | 13.5 | -1.4 | 0.5 | 2.6 | 6.6 | 4.3 | -0.1 | 9.9 | 2.5 | -6.7 | 1.3 | 6.2 | +44.9% |
| 2017 | 4.1 | 4.8 | -0.7 | -1.4 | 2.7 | 6.7 | -3.8 | -0.6 | 1.5 | 11.2 | 3.7 | -2.1 | +28.1% |
| 2016 | 8.2 | 0.5 | -8.2 | 0.4 | 8.8 | 2.2 | 10.8 | -2.5 | -5.5 | -7.5 | 5.9 | 3.4 | +15.3% |
| 2015 | 16.4 | 1.9 | 13.0 | -13.2 | -4.6 | -5.6 | 10.0 | -8.6 | -0.5 | 10.6 | 3.6 | -10.7 | +7.2% |
| 2014 | -5.1 | -2.6 | -3.1 | 14.1 | -0.2 | 1.3 | 0.5 | 3.6 | -0.5 | 4.2 | 5.6 | 11.0 | +30.9% |
| 2013 | 6.1 | 2.6 | 1.6 | 5.7 | 12.6 | -3.7 | 3.2 | 5.0 | 4.2 | -4.1 | -1.3 | -0.9 | +34.5% |
| 2012 | 10.9 | 0.7 | 8.7 | 9.0 | -3.1 | -3.2 | -1.3 | 20.8 | 5.2 | 0.5 | 2.6 | -0.8 | +59.5% |
| 2011 | -8.3 | -2.8 | -6.4 | 1.4 | 2.0 | -4.7 | -4.9 | 4.0 | 3.5 | -7.8 | -5.5 | -3.5 | −29.2% |
| 2010 | -2.4 | 11.1 | 8.9 | 1.1 | 5.9 | -3.6 | 0.1 | -6.4 | -0.3 | 0.9 | -1.2 | 3.6 | +17.7% |
| 2009 | 15.7 | -3.1 | -11.8 | 1.9 | -14.4 | 12.3 | -4.8 | 10.1 | -4.6 | 5.0 | 1.1 | 7.6 | +10.6% |
| 2008 | -14.8 | -14.2 | 3.9 | 1.5 | -10.7 | -11.5 | 9.4 | 35.8 | 0.2 | -8.3 | 8.7 | -0.4 | −9.9% |
| 2007 | 6.3 | -9.8 | 2.8 | -16.3 | 3.4 | -10.6 | 5.0 | -0.8 | -2.6 | -8.2 | 14.9 | 15.1 | −6.0% |
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Buy / hold / sell counts
No recent headlines.